Defective Products / Mass Torts

For years, CPM has been on the forefront of defective product litigation, fighting for those injured by dangerous products such as pharmaceuticals, automobiles, and machinery. The skilled attorneys at CPM have vast knowledge of product liability law, and have served as lead counsel in numerous class action and multi-district litigation cases.

For those whose lives have been harmed by a defective product, it can be difficult to know where to turn in order to hold manufacturers accountable and seek justice. CPM has represented hundreds of plaintiffs in dangerous products litigation, and has proven success securing financial compensation for those who have been injured or lost loved ones as a result of defective products.

RECENT CASES OF NOTE

In re: General Motors LLC Defective Ignition Switch Litigation
USDC, Southern District of New York
CPM represents a number of individuals in a class action lawsuit against General Motors for installing a dangerous ignition switch in over 6 million vehicles from 2003 to 2011.  The ignition switch defect caused the motor engine and certain electrical components, such as power-assisted steering, anti-lock brakes, and airbags, to abruptly turn off.  The lawsuits allege that, for over a decade, General Motors knew the ignition switch contained a design defect but did not notify the public until its first of many recalls in February 7, 2014. 

Toyota Litigation
USDC Central District of California
CPM is Co-Lead counsel in a class action against Toyota Motor Corporation and its U.S. sales and marketing arms, Toyota Motor Sales, U.S.A., Inc. and Toyota Motor North America, Inc.  United States District Judge James V. Selna appointed Frank M. Pitre as Co-Lead Counsel for the economic loss committee in the Toyota lawsuits.  The MDL involves more than 200 lawsuits divided into two groups: those seeking losses on behalf of consumers and others who have lost value on their Toyotas, and those seeking damages for people who have been injured or killed in a Toyota vehicle.  On July 24, 2013, United States District Judge James V. Selna granted final approval of the settlement wherein Toyota agreed to pay a total of 1.3 billion over financial losses associated with acceleration problems reported in some Toyota and Lexus vehicles. Under the settlement, Toyota agreed to provide installation of brake override systems for many Toyota and Lexus models and agreed to establish a $250 million fund to compensate class members for economic losses suffered because they sold or traded in a vehicle or terminated a lease during a period when the car's value was diminished due to negative publicity.  

Bextra and Celebrex Marketing Sales Practices and Product Liability Litigation
USDC Northern District of California
CPM was co-lead trial counsel in the In Re: Bextra and Celebrex Mktg., Sales Practices & Product Liability Litigation, which culminated in Pfizer agreeing to pay $894 million to settle consolidated injury and class action cases related to its pain killers Bextra & Celebrex.

Vioxx Product Liability Litigation
USDC Northern District of New York
CPM successfully represented a number of individuals who suffered medical injuries such as heart attacks and strokes after taking the prescription drug Vioxx.  The drug was withdrawn from the market by its manufacturer and distributor, Merck & Co., Inc., after evidence emerged linking the drug to heart attacks, strokes, sudden cardiac death and other serious cardiovascular risks.

In re: Porsche Cars North America, Inc. Plastic Coolant Tubes Products Liability Litigation
USDC Southern District of Ohio
CPM is co-Lead Counsel in a class action lawsuit against Porsche Cars North America, Inc. ("Porsche"), regarding defective coolant pipes in Porsche Cayenne model vehicles. The lawsuits allege, generally, that Porsche knowingly manufactured Cayenne models with plastic coolant tubes that degrade and fracture causing engine coolant to leak into the engine, leading to significant engine damage, and hid its knowledge of the defect from Cayenne owners. When the plastic coolant tubes fail, Cayenne owners are forced to purchase and install a costly "update kit" from Porsche which contains aluminum coolant pipes.

Diet Drug Litigation
Los Angeles County Superior Court
USDC Eastern District of Pennsylvania
CPM successfully represented approximately 100 individuals in consumer fraud and product liability individual actions.

Rhonda Albom, et al. v. Ford Motor Company/Firestone Tires
Los Angeles Superior Court
CPM represented a young child and her mother who were injured when their Ford Explorer veered out of control and rolled over in Half Moon Bay, California.  The case was one of several against Ford Motor Company and Firestone Tires consolidated before the Superior Court of Los Angeles.

Swine Flu Immunization Products Litigation
Adleson v. United States
USDC Northern District of California
USDC District of Columbia
MDL actions for product liability.

Bausch & Lomb Contact Lens Solution Product Liability Litigation
USDC District of South Carolina
CPM represented individuals who sustained serious eye injuries as a result of the use of the contact lens solution ReNu with MoistureLoc.  The product was withdrawn from the market by its manufacturer and distributor, Bausch & Lomb, after it was associated with fungal keratitis (a rare type of eye infection).

Dephlia Davis, et al. v. Actavis Group, et al.
USDC Northern District of California
CPM represented individuals who were injured or killed after injecting the drug Digitek, which was formulated and distributed by the manufacturers and suppliers at a level more than double the FDA prescribed maximum.

Trawick v. Parker-Hammifin, et al.
Monterey County Superior Court
CPM successfully prosecuted a product liability claim against the manufacturer and supplier of a defective rubber hose coupling installed on a forklift which failed and killed a construction foreman at the Monterey Plaza Hotel.

Munoz, et al. v. Bayer Corporation, et al.
San Joaquin County Superior Court
CPM successfully represented multiple individuals who were killed or injured after ingesting the drug Baycol, which was promoted by Bayer Pharmaceutical without alerting users of a severe muscle adverse reaction known as rhabdomyolysis.

Key Contacts

News